Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta adrenergic blocking agents for open-angle glaucoma.

M E Lee

    Journal of the American Optometric Association
    |July 1, 1988
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison of microscopic and molecular enumeration methods for insect viruses: Cryptophlebia leucotreta granulovirus as a case study.

    Journal of virological methods·2018
    Same author

    Nanoconfinement effects of chemically reduced graphene oxide nanoribbons on poly(vinyl chloride).

    Nanoscale·2018
    Same author

    Using total internal reflection fluorescence microscopy to visualize rhodopsin-containing cells.

    Applied and environmental microbiology·2015
    Same author

    Using genetic profiles of African forest elephants to infer population structure, movements, and habitat use in a conservation and development landscape in Gabon.

    Conservation biology : the journal of the Society for Conservation Biology·2014
    Same author

    Extent and ecological consequences of hunting in Central African rainforests in the twenty-first century.

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2013
    Same author

    Low oxygen tension enhances hepatitis C virus replication.

    Journal of virology·2012
    Same journal

    Visual skills profiles.

    Journal of the American Optometric Association·2014
    Same journal

    Dark adaptation and night blindness.

    Journal of the American Optometric Association·2014
    Same journal

    Scleral tonometry.

    Journal of the American Optometric Association·2014
    Same journal

    Staying in shape: the different roads to fitness for busy optometrists.

    Journal of the American Optometric Association·2000
    Same journal

    Hiring a new optometrist? Be prepared!

    Journal of the American Optometric Association·2000
    Same journal

    Late traumatic intraocular lens extrusion after penetrating keratoplasty.

    Journal of the American Optometric Association·2000
    See all related articles

    Ophthalmic beta blockers are effective for treating open-angle glaucoma by lowering intraocular pressure. This review compares three FDA-approved agents: timolol, levobunolol, and betaxolol, for optometrists.

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Open-angle glaucoma is a common condition requiring effective intraocular pressure (IOP) management.
    • Beta adrenergic blocking agents represent a significant advancement in antiglaucoma therapy.
    • These agents are widely accepted due to their efficacy and generally favorable tolerability.

    Purpose of the Study:

    • To enhance optometrists' understanding of ophthalmic beta adrenergic blocking agents.
    • To provide a comparative evaluation of the clinical pharmacology of key beta blockers used in glaucoma treatment.

    Main Methods:

    • Review of the clinical pharmacology of FDA-approved ophthalmic beta blockers.
    • Comparative analysis of timolol, levobunolol, and betaxolol.

    Main Results:

    Related Experiment Videos

    • Ophthalmic beta blockers are generally effective in reducing elevated intraocular pressure.
    • The evaluated agents demonstrate varying pharmacological profiles.
    • These medications are typically well-tolerated by patients.

    Conclusions:

    • Ophthalmic beta blockers are a valuable therapeutic option for open-angle glaucoma.
    • Understanding the specific pharmacology of timolol, levobunolol, and betaxolol is crucial for optometrists.
    • Informed selection and monitoring of these agents can optimize patient outcomes in glaucoma management.